MaxCyte (LSE:MXCT) Total Assets : £202.99 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is MaxCyte Total Assets?

MaxCyte's Total Assets for the quarter that ended in Mar. 2024 was £202.99 Mil.

Warning Sign:

If a company builds assets at 61.9% a year, faster than its revenue growth rate of 4.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, MaxCyte's average Total Assets Growth Rate was 68.60% per year. During the past 3 years, the average Total Assets Growth Rate was 84.10% per year. During the past 5 years, the average Total Assets Growth Rate was 61.90% per year. During the past 10 years, the average Total Assets Growth Rate was 49.90% per year.

During the past 12 years, MaxCyte's highest 3-Year average Total Assets Growth Rate was 84.10%. The lowest was 36.60%. And the median was 42.80%.

Total Assets is connected with ROA %. MaxCyte's annualized ROA % for the quarter that ended in Mar. 2024 was -14.45%. Total Assets is also linked to Revenue through Asset Turnover. MaxCyte's Asset Turnover for the quarter that ended in Mar. 2024 was 0.04.

MaxCyte Total Assets Historical Data

The historical data trend for MaxCyte's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MaxCyte Total Assets Chart

MaxCyte Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

22.88

38.52

213.66

235.34

211.94

MaxCyte Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															231.99	214.79	215.52	211.94	202.99

MaxCyte Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

MaxCyte's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	183.412	+	28.525
	=	211.94

MaxCyte's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	178.145	+	24.846
	=	202.99

MaxCyte (LSE:MXCT) Total Assets Explanation

Total Assets is connected with ROA %.

MaxCyte's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-29.988	/	( (211.936	+	202.991)	/ 2 )
	=	-29.988	/	207.4635
	=	-14.45 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

MaxCyte's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	8.926	/	( (211.936	+	202.991)	/ 2 )
=	8.926	/	207.4635
=	0.04

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

MaxCyte Total Assets Related Terms

Thank you for viewing the detailed overview of MaxCyte's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

MaxCyte (LSE:MXCT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (LSE:MXCT) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

MXCT:USA MYE0:Germany

Address

9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850

Website

https://www.maxcyte.com

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.